CATX · Perspective Therapeutics, Inc. · Webcasts, Transcripts & Audio
$2.57
-0.19 (-6.88%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$299.08M
Shares
114.15M
Volume · Oct 5
3.56M
Avg daily vol (3M)
1.64M
Perspective Therapeutics, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Perspective Therapeutics, Inc. (CATX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲20.3%
$2.31M
−$816,000
'20 Q1
20-05-12
▲14.7%
$2.21M
−$897,000
'20 Q2
20-09-17
·
$2.88M
−$545,000
'20 Q3
20-11-10
·
$2.28M
−$1.19M
'20 Q4
21-02-03
▲3%
$2.38M
−$713,000
'21 Q1
21-05-13
▲6.9%
$2.36M
−$868,000
'21 Q2
21-09-21
▼9.7%
$2.60M
−$745,000
'21 Q3
21-11-10
▲18.9%
$2.71M
−$1.06M
'21 Q4
22-02-08
▲7.6%
$2.56M
−$2.24M
'22 Q1
22-05-10
▲19.4%
$2.82M
−$1.60M
'22 Q2
22-09-28
LATEST
▲11.9%
$2.91M
−$1.35M
'22 Q3
22-11-10
Conference
Investor event
2026-09-16
Perspective Therapeutics, Inc. (CATX) September 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-16
Perspective Therapeutics, Inc. (CATX) September 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY24 · Q4
2025-01-13
Perspective Therapeutics, Inc. (CATX) Q4 2024 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Perspective Therapeutics, Inc. (CATX) Q3 2024 Earnings Call
Diluted EPS
$-0.21
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q3
2022-11-10
Perspective Therapeutics, Inc. (CATX) Q3 2022 Earnings Call Transcript
Revenue
$2.91M
▲ 11.9% YoY Gross margin
49.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-09-28
Perspective Therapeutics, Inc. (CATX) Q2 2022 Earnings Call Transcript
Revenue
$2.82M
▲ 19.4% YoY Gross margin
43.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Perspective Therapeutics, Inc. (CATX) Q1 2022 Earnings Call Transcript
Revenue
$2.56M
▲ 7.6% YoY Gross margin
40.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-08
Perspective Therapeutics, Inc. (CATX) Q4 2021 Earnings Call Transcript
Revenue
$2.71M
▲ 18.9% YoY Gross margin
49.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Perspective Therapeutics, Inc. (CATX) Q3 2021 Earnings Call Transcript
Revenue
$2.60M
▼ 9.7% YoY Gross margin
52.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-09-21
Perspective Therapeutics, Inc. (CATX) Q2 2021 Earnings Call Transcript
Revenue
$2.36M
▲ 6.9% YoY Gross margin
49.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Perspective Therapeutics, Inc. (CATX) Q1 2021 Earnings Call Transcript
Revenue
$2.38M
▲ 3% YoY Gross margin
52.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-03
Perspective Therapeutics, Inc. (CATX) Q4 2020 Earnings Call Transcript
Revenue
$2.28M
Gross margin
47.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-10
Perspective Therapeutics, Inc. (CATX) Q3 2020 Earnings Call Transcript
Revenue
$2.88M
Gross margin
59.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-09-17
Perspective Therapeutics, Inc. (CATX) Q2 2020 Earnings Call Transcript
Revenue
$2.21M
▲ 14.7% YoY Gross margin
50.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-12
Perspective Therapeutics, Inc. (CATX) Q1 2020 Earnings Call Transcript
Revenue
$2.31M
▲ 20.3% YoY Gross margin
53.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-11
Perspective Therapeutics, Inc. (CATX) Q4 2019 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–16 of 16 webcasts